BLOG
Patent analysis and insight
Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.
BLOG
Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.
Juristat Data Layer is now available inside Solve Intelligence, so patent teams can draft and prosecute against more than 20 years of real patent prosecution history from inside the tool they already use.
By Lauren Bonner, CEO, Juristat. Current as of September 2026. Rejection-rate figures below are drawn from Juristat's USPTO prosecution dataset; date window pending a data-team pull.
Sophisticated competitive analysis that previously required significant time and resources now takes minutes, not days — and is winning pitches.
Customer: Sterne, Kessler, Goldstein & Fox. Speaker: Dan Block, Director. Product: Juristat Data Layer (MCP), used inside Claude. Based on a recorded customer interview, August 2026.
Which Tech Center, which art unit, which CPC class. Get it wrong and you're not just off by a guess, you're setting the wrong prosecution strategy, quoting the wrong timeline, maybe filing claims that were worth rewriting first. Most classification tools answer that question by matching keywords against whatever art happens to be sitting in an index somewhere, and if that index hasn't been updated in years, neither has the prediction.
This fall, in-house IP teams are facing a familiar ritual: pull last year's numbers, brace for a budget cut, and figure out what to trim without gutting the portfolio's real value. On Tuesday, I participated in a IPWatchdog webinar with Gene Quinn and Jason Harrier (AI Patent Counsel, Salesforce) that tackled this exact problem: how AI is reshaping the budgeting and cost-cutting process for 2027, and what teams of any size can do about it right now.
The rules for challenging a competitor's patent have fundamentally changed in 2026. Inter partes review (IPR) petitions have dropped 65% year-over-year to historic lows. Ex parte reexamination has overtaken IPR as the leading post-grant validity tool for the first time since the America Invents Act. Post-grant review (PGR) windows are closing fast, and third-party pre-issuance submissions are drawing renewed attention from IP strategists. If your patent challenge playbook hasn't been updated, it's already outdated.
Notes from the IP Counsel Cafe Silicon Valley Meeting on what AI is actually doing for in-house IP teams: real efficiency, fragmented workflows, and the growing gap between client expectations and firm reality.
In the world of IP law, efficiency is key. As patent practitioners know all too well, manually managing the flow of information disclosure statements can be a cumbersome and time-consuming process.
The COVID-19 pandemic launched a healthcare innovation race without parallel in recent history. Recognizing the need for swift action, companies large and small across the healthcare industry jumped into action to do their part to develop diagnostics, therapeutics, and vaccines for COVID-19. Now that roughly two years have passed since the peak of the pandemic, we have a fuller body of COVID-19-related patenting data from the USPTO and patent offices around the world. While several studies have analyzed COVID-19-related patents — notably, the WIPO 2022 study of COVID-19 vaccines and therapeutics — none have focused specifically on COVID-19 diagnostics patents.
Will an interview lead to an allowance? Should you appeal? Is it time to abandon? How long is too long between filing and the first office action? As an experienced patent professional, you know that predicting examiner behavior is key to finding the shortest path to an allowance, but without the right data, you’re just guessing.
Maybe you were taken in by an ad for workflow automation that could help your overworked support staff, maybe you hit the search bar looking for a way to reduce your IDS workload, or maybe you were tired of the other firms standing out to corporate clients with their use of data analytics.
When it comes to office actions and your patent prosecution strategy, less is definitely more. Less time, less work, more profit, and more satisfied clients. Based on Juristat’s recent ranking though, some USPTO examiners might be thinking more is more.
2020 is not exactly what we expected, was it? Business has felt anything but usual. Now, at the end of the year, we have time to reflect, consider new best practices and areas of improvement, and keep our fingers crossed that 2021 will be at least a tiny bit less surprising.
The eligibility requirements for the Program are fairly straightforward. To qualify for fast-track status, the following four conditions must be met:
This past year, we’ve seen our industry innovate and adapt like never before. Time and time again, we talk to clients and colleagues who are discovering innovative ways to streamline budgets without sacrificing quality patent work. Our latest updates are designed to help you in these endeavors – adding greater speed and insight to our already easy-to-use analytics platform. Here is a quick summary of our exciting new features:
Patent prosecution is expensive and complex. And often, each individual practitioner has their own unique approach to reach that all-important NOA. But inconsistent practices and reliance solely on past experience can lead to inflated costs.
Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.